Tokyo, March 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000050828) titled 'A Retrospective Study to Investigate the Efficacy and Safety of Hemostatic Forceps Cutting in Endoscopic Treatment of Gastrointestinal Tumors' on March 31.
Study Type:
Observational
Primary Sponsor:
Institute - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University
Condition:
Condition - Gastrointestinal tumors
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The study will evaluate the completion rate of endoscopic submucosal dissection (ESD) of gastrointestinal tumors, including the use of high-frequency hemostatic forceps to remove blood vessels and fibrosis, as well as the use of additional devices and the presence or absence of damage to resected tissue.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who meet all of the following criteria will be considered
1) Patients undergoing ESD for gastrointestinal tumors and early-stage gastrointestinal cancers.
2) Tissue resection using high-frequency hemostatic forceps is performed during the procedure in 1).
3) Pathological examination of excised lesions is performed.
4) All necessary data collection items are recorded in the electronic medical record.
Key exclusion criteria - A case of difficult ESD in which a scissors knife was planned to be used preoperatively
Target Size - 40
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2021 Year 04 Month 26 Day
Date of IRB - 2021 Year 06 Month 23 Day
Anticipated trial start date - 2021 Year 04 Month 26 Day
Last follow-up date - 2025 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057925
Disclaimer: Curated by HT Syndication.
